| CAS ID: | 51-48-9 |
| Molecular Formula: | C15H11I4NO4 |
| Molecular Weight: | 776.9 g/mol |
| Monoisotopic Mass: | 776.6867 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | LEVOTHYROXINE SODIUM | LEVOLET | LEVO-T | LEVOXYL | Tetramet | Levothyroid | Soloxine | UNITHROID | T4 | TIROSINT | SYNTHROID | Levothyroxine | LEVOTHROID | EVOTROX | THYROXINE | TIROSINT-SOL | Thyrol L | ELTROXIN | L-THYROXINE HENNING | T4 (LIOTRIX) | THYROXINE I 131 | NOVOTHYROX | THYRO-TABS | THYROXINE I 125 | Levoxine |
| Analysis: | Drug repositioning mechanism analysis |
Trial Record 1
| ClinicalTrial ID | NCT02512978 | Disease | Cardiac fibrosis |
| Phase | Phase 4 | Status | Recruiting |
| First Received | July 31, 2015 | Last Verified | July 16, 2018 |
| Sponsor | Chinese Academy of Medical Sciences, Fuwai Hospital | ||
| PubChem: | 5819 |
| ChEMBL: | CHEMBL1624 |